Avacopan is a complement C5a receptor antagonist used in the treatment of ANCA-associated vasculitis. It reduces inflammation by blocking the C5a receptor on immune cells. This allows for reduced use of corticosteroids, improving long-term safety.
Avacopan is a complement C5a receptor antagonist used in the treatment of ANCA-associated vasculitis. It reduces inflammation by blocking the C5a receptor on immune cells. This allows for reduced use of corticosteroids, improving long-term safety.
Cardiovascular
(2R,3S)-2-[4-(cyclopentylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-methyl-3-(trifluoromethyl)phenyl]piperidine-3-carboxamide
C33H35F4N3O2C33H35F4N3O2